Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares

Omega Fund Management reduced its KMTS stake by 351,442 shares in Q1, an estimated $8.28 million sale based on quarterly average pricing. The move is a modest flow/positioning signal rather than a fundamental catalyst, and by itself is unlikely to materially affect the stock.

Analysis

Omega Fund Management reduced its KMTS stake by 351,442 shares in Q1, an estimated $8.28 million sale based on quarterly average pricing. The move is a modest flow/positioning signal rather than a fundamental catalyst, and by itself is unlikely to materially affect the stock.